| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2015-05-13 | modified vaccinia Ankara (MVA) Ebola Zaire vaccine candidate (MVA EBOZ) | Ebola fever | 1 | GSK (UK) Emergent BioSolutions (USA - MD) University of Oxford (UK) | Infectious diseases |
| 2015-05-12 | ixazomib (MLN9708 - 2,2\'-{2-[(1R)-1-({[(2,5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid) | patients with newly diagnosed multiple myeloma who have responded to initial therapy and have not undergone an autologous stem cell transplant (ASCT) | 3 | Takeda Pharmaceutical (Japan) Millennium Pharmaceuticals (USA - MA) | Cancer - Oncology |
| 2015-05-12 | MVA-BN® Filo vaccine and the AdVac® vaccine (preventive Ebola vaccine) | Ebola fever | 1 | J&J (USA - NJ) Oxford Vaccines Group, part of the University of Oxford (UK) Bavarian Nordic (Denmark) | Infectious diseases |
| 2015-05-12 | alisertib | relapsed or refractory peripheral T-cell lymphoma (PTCL) | 3 | Takeda Pharmaceutical (Japan) | Cancer - Oncology |
| 2015-05-11 | octreotide capsules | acromegaly |
3 | Chiasma (USA- MA - Israel) | Hormonal diseases - Rare diseases - Endocrine diseases |
| 2015-05-11 | self-delivering RNAi (sd-rxRNA®) | RXi Pharmaceuticals (USA - MA) | Cancer - Oncology - Dermatological diseases | ||
| 2015-05-11 | porcupine inhibitor | breast cancer, head and neck cancer, pancreatic cancer | RedXPharma (UK) | Cancer - Oncology | |
| 2015-05-11 | selective kinase inhibitors | Blueprint Medicines (USA - MA) | Cancer - Oncology | ||
| 2015-05-11 | Dendritic Cell (DC) vaccines | acute myeloid leukaemia | 1-2 | Medigene (Germany) | Cancer - Oncology |
| 2015-05-11 | Fovista® | wet age-related macular degeneration (AMD) |
3 | Ophthotech (USA - NY) | Ophtalmological diseases |
| 2015-05-11 | ISTH0036 - antisense oligonucleotide directed against TGF-ß2 mRNA | glaucoma |
preclinical | Isarna Therapeutics (Germany) | Ophtalmological diseases |
| 2015-05-08 | Epi proColon® (colorectal cancer blood test) | colorectal cancer | Epigenomics (Germany - USA) | Cancer - Oncology - Diagnostic | |
| 2015-05-07 | synthetic cyclic dinucleotide (CDN) molecules | metastatic cancers |
preclinical | Aduro Biotech (USA - CA) | Cancer - Oncology |
| 2015-05-07 | JZP-386 (sodium oxybate analog) | 1 | Jazz Pharmaceuticals (Ireland) Concert Pharmaceuticals (USA - MA) | CNS diseases - Neurological diseases | |
| 2015-05-07 | Amitiza® (lubiprostone) | prevention of oral mucositis in patients suffering with head and neck cancer receiving concurrent radiation and chemotherapy |
2 | Sucampo Pharmaceuticals (USA - MD) | Cancer - Oncology - Inflammatory diseases |
| 2015-05-07 | ALX-0171 | Respiratory Syncytial Virus (RSV) infection |
preclinical | Ablynx (Belgium) | Infectious diseases - Respiratory diseases |
| 2015-05-06 | APD403 (amisulpride) | chemotherapy-induced nausea & vomiting (CINV) | 2 | Acacia Pharma (UK) | Cancer - Oncology |
| 2015-05-06 | OncoVAX® | stage II colon cancer | 3 | Vaccinogen (USA - MD) | Cancer - Oncology |
| 2015-05-06 | Nulojix® (belatacept) | kidney transplantation |
3 | BMS (USA - NY) | Transplantation |
| 2015-05-06 | GWP42006 (cannabidivarin) | epilepsy |
2 | GW Pharmaceuticals (UK) | CNS diseases - Neurological diseases |
